🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07505927
Recruiting Not applicable

Acupuncture for Postoperative Gastric Emptying Delay

NCT07505927 · tracked via the Priya Life Science China tracker
Sponsor
Qilu Hospital of Shandong University
Phase
Not applicable
Started
2026-04-01
Last updated
2026-07-15

Condition(s) studied

Gastroparesis PostoperativeDelayed Gastric Emptying Following Procedure

Investigational drug(s) / intervention(s)

Acupuncturesham acupuncture

Acupuncture: Intervention Description: Participants receive traditional Chinese medicine acupuncture administered using sterile filiform needles at acupoints selected based on clinical presentation. The treatment session duration and frequency are identical to those in the control group. All participants continue to receive standard postoperative care.

sham acupuncture: Participants receive sham acupuncture administered using identical filiform needles as the experimental group, with superficial insertion at non-acupoints and without needle manipulation. The treatment session duration and frequency are identical to those in the experimental group. All participants continue to receive standard postoperative care.

Study summary

This multicenter clinical trial, conducted at Qilu Hospital of Shandong University and collaborating institutions, prospectively assesses the efficacy and safety of acupuncture for postoperative delayed gastric emptying. Eligible participants will be prospectively enrolled and randomized into different groups per the study protocol. The primary endpoint is the reduction in the duration of delayed gastric emptying, while secondary endpoints include the complete resolution of cardinal gastroparetic symptoms, such as abdominal distension, nausea, and vomiting. All study procedures adhere to the ethical standards outlined in the approved protocol.

Eligibility

Sex
ALL
Min age
18 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: 1. Aged 18-80 years, regardless of sex. 2. Patients who have undergone partial gastrectomy. 3. Patients presenting with postoperative gastroparesis symptoms, confirmed by imaging or gastric emptying scintigraphy, and clinically diagnosed with gastroparesis. 4. No severe cardiac, hepatic, renal, or coagulation dysfunction. 5. No participation in other interventional clinical trials within the past month. 6. Able to provide written informed consent and comply with the treatment and follow-up procedures. Exclusion Criteria: 1. Patients with severe cardiovascular or cerebrovascular diseases, hepatic or renal failure, or coagulation disorders. 2. Patients who develop serious postoperative complications after partial gastrectomy, such as anastomotic leakage, gastrointestinal bleeding, or severe infections, or conditions that may affect the assessment of gastric motility, such as ascites or intestinal obstruction. 3. Patients with a known allergy to acupuncture or with skin damage, infection, or severe scarring at the needle insertion sites that would prevent proper acupoint selection or needling. 4. Patients with diagnosed psychiatric disorders, cognitive impairment, or those unable to cooperate with treatment procedures, symptom assessment, or follow-up. 5. Patients who have used medications that may significantly affect gastric motility within the past week and cannot discontinue their use. 6. Pregnant or breastfeeding women, or individuals with other special physiological conditions that may make them unsuitable for participation in acupuncture research.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Qilu hospital Jinan Shandong Recruiting

More Qilu Hospital of Shandong University trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07505927 on ClinicalTrials.gov ↗ ← All trials in China